Boston Partners’s NEOPHOTONICS CORP NPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-22,573
Closed -$347K 744
2021
Q4
$347K Sell
22,573
-68,193
-75% -$897K ﹤0.01% 635
2021
Q3
$791K Buy
90,766
+14,003
+18% +$128K ﹤0.01% 553
2021
Q2
$784K Buy
76,763
+6,413
+9% +$67.7K ﹤0.01% 578
2021
Q1
$841K Sell
70,350
-120,372
-63% -$1.36M ﹤0.01% 595
2020
Q4
$1.73M Buy
190,722
+54,416
+40% +$421K ﹤0.01% 457
2020
Q3
$831K Sell
136,306
-65,758
-33% -$502K ﹤0.01% 558
2020
Q2
$1.79M Sell
202,064
-16,963
-8% -$146K ﹤0.01% 438
2020
Q1
$1.59M Sell
219,027
-9,928
-4% -$73.6K ﹤0.01% 452
2019
Q4
$2.02M Sell
228,955
-65,912
-22% -$493K ﹤0.01% 488
2019
Q3
$1.8M Sell
294,867
-1,521,066
-84% -$8.55M ﹤0.01% 517
2019
Q2
$7.59M Sell
1,815,933
-213,571
-11% -$1.13M 0.01% 387
2019
Q1
$12.8M Sell
2,029,504
-713,476
-26% -$5M 0.02% 359
2018
Q4
$17.8M Buy
2,742,980
+1,395,000
+103% +$10.7M 0.03% 325
2018
Q3
$11.2M Sell
1,347,980
-39,040
-3% -$297K 0.01% 365
2018
Q2
$8.64M Sell
1,387,020
-402,500
-22% -$2.56M 0.01% 395
2018
Q1
$12.3M Buy
1,789,520
+1,494,520
+507% +$9.49M 0.01% 361
2017
Q4
$1.94M Sell
295,000
-43,800
-13% -$268K ﹤0.01% 671
2017
Q3
$1.88M Buy
+338,800
New +$2.29M ﹤0.01% 677
2015
Q1
Sell
-236,880
Closed -$801K 744
2014
Q4
$801K Buy
236,880
+127,680
+117% +$409K ﹤0.01% 680
2014
Q3
$366K Buy
+109,200
New +$341K ﹤0.01% 703

Other funds holding NPTN

Boston Partners's NPTN Position: Q1 2022 in Review

Boston Partners sold out of NEOPHOTONICS CORP (NPTN) in Q1 2022, closing a stake of 22,573 shares — an estimated $347K sold.

Boston Partners first reported a position in NPTN in Q3 2014 and held it in 20 quarters. The position peaked at $17.8M in Q4 2018. 143 funds tracked by Wall St. Rank hold NPTN as of Q1 2022.

  • Boston Partners reported no remaining NEOPHOTONICS CORP position as of Q1 2022 after selling out during the quarter.
  • Boston Partners sold 22,573 NEOPHOTONICS CORP shares in Q1 2022, an estimated $347K.
  • Boston Partners first reported a position in NEOPHOTONICS CORP in Q3 2014 and held it in 20 quarters.
  • Boston Partners's NEOPHOTONICS CORP position peaked at $17.8M in Q4 2018.
  • 143 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q1 2022.

Based on Boston Partners's 13F filing for Q1 2022, filed 10 May 2022.